Skip to main content

Protagen Raises $1.5M in Third Round of Financing

NEW YORK (GenomeWeb News) – Dortmund, Germany-based Protagen today said that it has raised €1 million ($1.5 million) in a third round of financing with private investors.
 
Protagen said it would use the funds to expand its protein biochips business. The firm said it has developed a unique protein biochip technology package, called UNIarray, for the discovery and validation of biomarkers.
 
It also is working on diagnostics for multiple sclerosis, rheumatoid arthritis, juvenile idiopathic arthritis, and Alzheimer’s disease.
 
Investors in this round of financing included Munich-based MIG AG and Co KG Beteiligungsfonds 3, S-Venture Capital Dortmund, and Kreditanstalt für Wiederaufbau.
 
Protagen has raised a total of €5.3 million since 2004.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.